Diagnosis and treatment of alk-7 related disorders
    1.
    发明申请
    Diagnosis and treatment of alk-7 related disorders 审中-公开
    alk-7相关疾病的诊断和治疗

    公开(公告)号:US20050026184A1

    公开(公告)日:2005-02-03

    申请号:US10849244

    申请日:2004-05-20

    摘要: The present invention relates to ALK-7 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for ALK-7 related diseases or conditions characterized by an abnormal interaction between an ALK-7 polypeptide and an ALK-7 binding partner.

    摘要翻译: 本发明涉及ALK-7多肽,编码这种多肽的核酸,含有此类核酸的细胞,组织和动物,这种多肽的抗体,利用这些多肽的测定法,以及涉及上述所有方法的方法。 提供ALK-7相关疾病或ALK-7多肽与ALK-7结合配偶体异常相互作用特征的治疗,诊断和筛选方法。

    Diagnosis and treatment of alk-7 related disorders
    2.
    发明授权
    Diagnosis and treatment of alk-7 related disorders 失效
    alk-7相关疾病的诊断和治疗

    公开(公告)号:US06818440B2

    公开(公告)日:2004-11-16

    申请号:US09069228

    申请日:1998-04-27

    IPC分类号: C12N1563

    摘要: The present invention relates to ALK-7 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for ALK-7 related diseases or conditions characterized by an abnormal interaction between an ALK-7 polypeptide and an ALK-7 binding partner.

    摘要翻译: 本发明涉及ALK-7多肽,编码这种多肽的核酸,含有此类核酸的细胞,组织和动物,这种多肽的抗体,利用这些多肽的测定法,以及涉及上述所有方法的方法。 提供ALK-7相关疾病或ALK-7多肽与ALK-7结合配偶体异常相互作用特征的治疗,诊断和筛选方法。

    Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase
    4.
    发明授权
    Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase 失效
    用调节C-RET受体蛋白酪氨酸激酶功能的化合物预防和治疗神经障碍的方法

    公开(公告)号:US06235769B1

    公开(公告)日:2001-05-22

    申请号:US09109883

    申请日:1998-07-02

    申请人: Douglas Clary

    发明人: Douglas Clary

    IPC分类号: A61K3140

    CPC分类号: A61K31/40

    摘要: The invention relates in part to a method of preventing or treating an abnormal condition caused by an aberration in the function of the C-RET receptor, and specifically to the treatment and prevention of neurodegenerative disorders by administering a pharmaceutical composition that modulates the function of the C-RET receptor.

    摘要翻译: 本发明部分地涉及一种预防或治疗由C-RET受体的功能异常引起的异常状况的方法,特别涉及治疗和预防神经变性疾病的方法,该方法是通过施用调节功能的药物组合物 C-RET受体。